Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia Health System, PO Box 801410, Charlottesville, VA 22908.
Hypertension. 2014 Jun;63(6):1219-27. doi: 10.1161/HYPERTENSIONAHA.113.03025. Epub 2014 Apr 7.
Angiotensin-(1-7) [Ang-(1-7)], an endogenous ligand for the G protein-coupled receptor Mas, exerts both vasodilatory and insulin-sensitizing effects. In skeletal muscle, relaxation of precapillary arterioles recruits microvasculature and increases the endothelial surface area available for nutrient and hormone exchanges. To assess whether Ang-(1-7) recruits microvasculature and enhances insulin action in muscle, overnight-fasted adult rats received an intravenous infusion of Ang-(1-7) (0, 10, or 100 ng/kg per minute) for 150 minutes with or without a simultaneous infusion of the Mas inhibitor A-779 and a superimposition of a euglycemic insulin clamp (3 mU/kg per minute) from 30 to 150 minutes. Hind limb muscle microvascular blood volume, microvascular flow velocity, and microvascular blood flow were determined. Myographic changes in tension were measured on preconstricted distal saphenous artery. Ang-(1-7) dose-dependently relaxed the saphenous artery (P<0.05) ex vivo. This effect was potentiated by insulin (P<0.01) and abolished by either endothelium denudement or Mas inhibition. Systemic infusion of Ang-(1-7) rapidly increased muscle microvascular blood volume and microvascular blood flow (P<0.05, each) without altering microvascular flow velocity. Insulin infusion alone increased muscle microvascular blood volume by 60% to 70% (P<0.05). Adding insulin to the Ang-(1-7) infusion further increased muscle microvascular blood volume and microvascular blood flow (≈2.5 fold; P<0.01). These were associated with a significant increase in insulin-mediated glucose disposal and muscle protein kinase B and extracellular signal-regulated kinase 1/2 phosphorylation. A-779 pretreatment blunted the microvascular and insulin-sensitizing effects of Ang-(1-7). We conclude that Ang-(1-7) by activating Mas recruits muscle microvasculature and enhances the metabolic action of insulin. These effects may contribute to the cardiovascular protective responses associated with Mas activation and explain the insulin-sensitizing action of Ang-(1-7).
血管紧张素-(1-7)[Ang-(1-7)],一种 G 蛋白偶联受体 Mas 的内源性配体,具有血管舒张和胰岛素增敏作用。在骨骼肌中,前毛细血管小动脉的舒张募集微血管,并增加用于营养和激素交换的内皮表面积。为了评估 Ang-(1-7)是否招募微血管并增强肌肉中的胰岛素作用, overnight-fasted 成年大鼠接受 Ang-(1-7)(0、10 或 100ng/kg/min)静脉输注 150 分钟,同时输注 Mas 抑制剂 A-779,并从 30 分钟到 150 分钟叠加一个 euglycemic insulin clamp(3mU/kg/min)。测量后肢肌肉微血管血液体积、微血管血流速度和微血管血流量。在预收缩的远端隐静脉测量张力的肌电图变化。Ang-(1-7)剂量依赖性地舒张隐静脉(P<0.05)离体。这种作用被胰岛素增强(P<0.01),并且被内皮剥脱或 Mas 抑制消除。系统输注 Ang-(1-7)迅速增加肌肉微血管血液体积和微血管血流量(P<0.05,各)而不改变微血管血流速度。单独输注胰岛素可使肌肉微血管血液体积增加 60%至 70%(P<0.05)。将胰岛素加入 Ang-(1-7)输注中进一步增加肌肉微血管血液体积和微血管血流量(≈2.5 倍;P<0.01)。这与胰岛素介导的葡萄糖摄取和肌肉蛋白激酶 B 和细胞外信号调节激酶 1/2 磷酸化的显著增加有关。A-779 预处理减弱了 Ang-(1-7)的微血管和胰岛素增敏作用。我们的结论是,Ang-(1-7)通过激活 Mas 募集肌肉微血管并增强胰岛素的代谢作用。这些作用可能有助于与 Mas 激活相关的心血管保护反应,并解释 Ang-(1-7)的胰岛素增敏作用。